Related references
Note: Only part of the references are listed.Assessing the Cost Utility of Response-Guided Therapy in Patients with Chronic Hepatitis C Genotype 1 in the UK Using the MONARCH Model
Phil McEwan et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in US Primary Care Settings
David B. Rein et al.
ANNALS OF INTERNAL MEDICINE (2012)
Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention
Bryce D. Smith et al.
ANNALS OF INTERNAL MEDICINE (2012)
Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C
Phillip O. Coffin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Hepatitis B and C Virus Infection Among 1.2 Million Persons With Access to Care: Factors Associated With Testing and Infection Prevalence
Philip R. Spradling et al.
CLINICAL INFECTIOUS DISEASES (2012)
Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
Calogero Camma et al.
HEPATOLOGY (2012)
Economic model of a birth cohort screening program for hepatitis C virus
Lisa J. McGarry et al.
HEPATOLOGY (2012)
Incidence and Transmission Patterns of Acute Hepatitis C in the United States, 1982-2006
Ian T. Williams et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Ju Dong Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States
David B. Rein et al.
DIGESTIVE AND LIVER DISEASE (2011)
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
Natasha K. Martin et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting
W. N. Southern et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Hepatitis C virus infection in USA: an estimate of true prevalence
Eric Chak et al.
LIVER INTERNATIONAL (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Management of Acute Hepatitis C
Anurag Maheshwari et al.
Clinics in Liver Disease (2010)
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3
David R. Nelson et al.
GASTROENTEROLOGY (2010)
Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Hepatitis C Patients with Advanced Fibrosis and Cirrhosis
Savino Bruno et al.
HEPATOLOGY (2010)
The Institute of Medicine Report on Viral Hepatitis: A Call to Action
Arun J. Sanyal
HEPATOLOGY (2010)
Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
G. Sroczynski et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Public Health Impact of Antiviral Therapy for Hepatitis C in the United States
Michael L. Volk et al.
HEPATOLOGY (2009)
Liver and intestine transplantation in the United States, 1997-2006
R. B. Freeman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis
J. Thompson Coon et al.
BRITISH JOURNAL OF CANCER (2008)
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
Hla-Hla Thein et al.
HEPATOLOGY (2008)
Health-state utilities in liver disease: A systematic review
David J. McLernon et al.
MEDICAL DECISION MAKING (2008)
Epidemiology of hepatocellular carcinoma in USA
Hashem B. El-Serag
HEPATOLOGY RESEARCH (2007)
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States
S. Deuffic-Burban et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States
Omana V. Nainan et al.
GASTROENTEROLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
Estimation of utilities for chronic hepatitis C from SF-36 scores
HH Thein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database
MS Roberts et al.
LIVER TRANSPLANTATION (2004)
Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population
JA Salomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
RF Velázquez et al.
HEPATOLOGY (2003)
Share Paper
